LEX-WK-PCNZPM8Acrawled 2021-10-26 10:44Z
Amgen Faces “Uphill Battle” in Defending Antibody Genus Patentability
Caitlin M. Wilmot · Biosimilars Law Bulletin · Published February 11, 2021
Work details
- author
- Caitlin M. Wilmot
- firm or organization
- Rothwell Figg
- publication
- Biosimilars Law Bulletin
- practice area
- Intellectual Property
- published
- 2021-02-11
Citation
Caitlin M. Wilmot, Amgen Faces “Uphill Battle” in Defending Antibody Genus Patentability, Biosimilars Law Bulletin (February 11, 2021) [The Library at LexBlog, LEX-WK-PCNZPM8A, lexpid.org/PCNZPM8A]